Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Adverse Impact of Tumor Microenvironment on NK-Cell
Ziming Hu, Xiuxiu Xu, Haiming Wei
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Natural killer cell homing and trafficking in tissues and tumors: from biology to application
Guanghe Ran, Yu qing Lin, Lei Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 140
Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Beibei Zhang, Mengzhe Yang, Weimin Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 25
The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review
Toufik Abdul‐Rahman, Shankhaneel Ghosh, Sarah M. Badar, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 19
Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy
Xin Lian, Kailin Yang, Renliang Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 66
Immunotherapy resistance in non-small-cell lung cancer: From mechanism to clinical strategies
Suna Zhou, Haihua Yang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Natural killer cells suppress cancer metastasis by eliminating circulating cancer cells
Maulik Vyas, Marta Requesens, Thao H. Nguyen, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 23
Therapeutic strategies for gastric cancer targeting immune cells: Future directions
Yan Zhao, Yuansong Bai, Meili Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
Barbara Seliger, Ulrike Koehl
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer
Éilis Russell, Melissa J. Conroy, Martin P. Barr
Cells (2022) Vol. 11, Iss. 4, pp. 605-605
Open Access | Times Cited: 21
Emerging frontiers in immuno- and gene therapy for cancer
Michael P. Gustafson, John A. Ligon, Alexey Bersenev, et al.
Cytotherapy (2022) Vol. 25, Iss. 1, pp. 20-32
Open Access | Times Cited: 15
Understanding the Interplay of CAR-NK Cells and Triple-Negative Breast Cancer: Insights from Computational Modeling
Abazar Arabameri, Samaneh Arab
Bulletin of Mathematical Biology (2024) Vol. 86, Iss. 2
Closed Access | Times Cited: 2
miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells
Wei‐An Chang, Ming‐Ju Tsai, Jen‐Yu Hung, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6252-6252
Open Access | Times Cited: 19
Single-cell pair-wise relationships untangled by composite embedding model
Sishir Subedi, Yongjin Park
iScience (2023) Vol. 26, Iss. 2, pp. 106025-106025
Open Access | Times Cited: 6
Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients
Denisa Baci, Elona Cekani, Andrea Imperatori, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies
Liping Wang, Zhe Chen, Guohong Liu, et al.
Genes & Diseases (2022) Vol. 10, Iss. 3, pp. 990-1004
Open Access | Times Cited: 10
Transcriptomic Profiling for Prognostic Biomarkers in Early-Stage Squamous Cell Lung Cancer (SqCLC)
Maja Šutić, Branko Dmitrović, Antonia Jakovčević, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 720-720
Open Access | Times Cited: 1
Real-time ex vivo monitoring of NK cell migration toward obesity-associated oesophageal adenocarcinoma following modulation of CX3CR1
Eimear Mylod, Fiona O’Connell, Noel E. Donlon, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Tri-specific killer engager: unleashing multi-synergic power against cancer
Peeranut Winidmanokul, Aussara Panya, Seiji Okada
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 2, pp. 432-448
Open Access | Times Cited: 1
Accumulation of CD56+ CD16- Natural Killer Cells in Response to Preoperative Chemotherapy for Breast Cancer
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, et al.
World Journal of Oncology (2024) Vol. 15, Iss. 4, pp. 682-694
Open Access | Times Cited: 1
KIR2DL2/DL3+NKs and Helios+Tregs in peripheral blood predict nivolumab response in patients with metastatic renal cell cancer
Sara Santagata, Anna Maria Trotta, Crescenzo D’Alterio, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 20, pp. 4755-4767
Open Access | Times Cited: 1
Altered NCR3 Splice Variants May Result in Deficient NK Cell Function in Renal Cell Carcinoma Patients
XUELEI WANG, Liqun Huang, Xiaofei Wen, et al.
In Vivo (2023) Vol. 38, Iss. 1, pp. 174-183
Open Access | Times Cited: 2
New Approaches in Gastric Cancer Immunotherapy
Pegah Mousavi, Ali Mohammad Ahmadi, Shakila Behzadifar, et al.
IntechOpen eBooks (2024)
Closed Access
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
The Diverse Roles of the Tumour Microenvironment in Carcinogenesis
Ismail Ibrahim Al-Janabi
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2024) Vol. 7, Iss. 2, pp. 26-37
Open Access
Targeting TRIM29 As a Negative Regulator of CAR-NK Cell Effector Function to Improve Antitumor Efficacy of these Cells: A Perspective
Zahra Saleh, Maryam Noroozi, Mahsa Eshkevar Vakili, et al.
Current Molecular Medicine (2023) Vol. 24, Iss. 4, pp. 399-403
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top